Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

444
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
444
Cross-reactivity00:42

Cross-reactivity

30.9K
Overview
30.9K
Vaccinations01:51

Vaccinations

43.9K
Overview
43.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The case for evaluation of double mutant heat-labile toxin as an adjuvant to improve oral cholera vaccine immunogenicity.

Frontiers in immunology·2026
Same author

Special Issue on Enterotoxigenic <i>Escherichia coli</i> (ETEC) Vaccines: ETEC Infection and Vaccine-Mediated Immunity.

Microorganisms·2024
Same author

Vaccine value profile for enterotoxigenic Escherichia coli (ETEC).

Vaccine·2023
Same author

Oral inactivated whole cell vaccine for mucosal immunization: ETVAX case study.

Frontiers in immunology·2023
Same author

Controlled Human Infection Models To Accelerate Vaccine Development.

Clinical microbiology reviews·2022
Same author

Induction of mucosal and systemic immune responses against the common O78 antigen of an oral inactivated ETEC vaccine in Bangladeshi children and infants.

Vaccine·2021
Same journal

Retraction notice to "Effectiveness of prescription-based influenza vaccination services among older adults in Binzhou, China: A cluster-randomized controlled trial" [Vaccine 82 (2026) 128588].

Vaccine·2026
Same journal

Barriers and facilitators to COVID-19 vaccination programme implementation in Ireland: a qualitative study of implementation stakeholders using CFIR.

Vaccine·2026
Same journal

Immunogenicity and safety of a SARS-CoV-2 recombinant vaccine S-268024 booster vaccination versus NVX-CoV2373: Interim results from a phase 3, multicenter, randomized, observer-blind, active-controlled study.

Vaccine·2026
Same journal

Safety and immunogenicity of a reduced, homologous booster dose of the BNT162b2 mRNA COVID-19 vaccine: a single blind, randomized, non-inferiority follow-up trial.

Vaccine·2026
Same journal

Vaccination policies for healthcare personnel in Europe, 2026.

Vaccine·2026
Same journal

A historical overview of the anti-vaccine movement and its public health implications.

Vaccine·2026
See all related articles

Related Experiment Video

Updated: May 29, 2025

Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes
13:53

Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes

Published on: December 19, 2020

4.9K

Conserved antigens for enteric vaccines.

Richard I Walker1

  • 1PATH, 455 Massachusetts Ave, Suite 1000, Washington, DC, 20001-2621, USA.

Vaccine
|February 6, 2025
PubMed
Summary
This summary is machine-generated.

Developing multi-pathogen vaccines against diarrheal diseases caused by ETEC, Shigella, and Campylobacter is crucial. A novel mucosal adjuvant, double mutant heat-labile toxin (dmLT), enhances immune responses to conserved antigens, paving the way for effective vaccines.

Keywords:
CampylobacterConserved antigensDouble mutant labile toxin (dmLT)ETECMulti-pathogen vaccineShigella

More Related Videos

Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle VLP-Based Vaccines Using a Capture Assay
05:15

Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle VLP-Based Vaccines Using a Capture Assay

Published on: February 10, 2022

3.5K
Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
00:10

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

Published on: August 21, 2019

7.5K

Related Experiment Videos

Last Updated: May 29, 2025

Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes
13:53

Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes

Published on: December 19, 2020

4.9K
Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle VLP-Based Vaccines Using a Capture Assay
05:15

Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle VLP-Based Vaccines Using a Capture Assay

Published on: February 10, 2022

3.5K
Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
00:10

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

Published on: August 21, 2019

7.5K

Area of Science:

  • Microbiology and Immunology
  • Vaccine Development
  • Infectious Diseases

Background:

  • Enterotoxigenic Escherichia coli (ETEC), Shigella, and Campylobacter are leading causes of diarrheal diseases and childhood stunting.
  • These pathogens contribute to approximately 30% of diarrheal disease cases and are recognized antimicrobial resistance (AMR) threats.
  • Currently, no licensed vaccines exist for these significant bacterial pathogens.

Purpose of the Study:

  • To review conserved antigens identified for ETEC, Shigella, and Campylobacter.
  • To explore strategies for developing multi-pathogen vaccines against these diarrheal disease agents.
  • To highlight the potential of the mucosal adjuvant, double mutant heat-labile toxin (dmLT), in enhancing vaccine efficacy.

Main Methods:

  • Identification of conserved antigens across ETEC, Shigella, and Campylobacter.
  • Evaluation of strategies for antigen consolidation, such as cellular vectors and conjugate vaccines.
  • Assessment of the adjuvant properties of double mutant heat-labile toxin (dmLT) for oral and intramuscular administration.

Main Results:

  • Conserved antigens have been identified for ETEC, Shigella, and Campylobacter, enabling the potential development of multi-pathogen vaccines.
  • Double mutant heat-labile toxin (dmLT) acts as a mucosal adjuvant and elicits robust immune responses.
  • dmLT demonstrates efficacy in enhancing immune responses when co-administered with antigens.

Conclusions:

  • Conserved antigens offer a promising avenue for creating effective multi-pathogen vaccines against major diarrheal pathogens.
  • The novel mucosal adjuvant dmLT significantly boosts both mucosal and systemic immunity.
  • Strategic use of conserved antigens with adjuvants like dmLT can substantially reduce the burden of diarrheal diseases.